CAS RN: 134523-00-5

Atorvastatin

Product Availability

Choose a grade to view its available package options.

9 package records5 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250107 100mg Out of stock Inquiry
Batchno.20250302 1g Out of stock Inquiry
Batchno.20250216 1mg In stock Shanghai Inquiry
Batchno.20250318 250mg Out of stock Inquiry
Batchno.20260624 5g Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250502 10mg In stock Shanghai, Hebei Inquiry
Batchno.20260419 1g In stock Shanghai Inquiry
Batchno.20250310 250mg In stock Shanghai, Guangdong Inquiry
Batchno.20250827 50mg In stock Shanghai, Chongqing Inquiry
  • Product code: starshine_CAS134523-00-5
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

134523-00-5 / (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid

Standard CAS: 134523-00-5 Multi CAS: No

Basic Information

CAS
134523-00-5
Multi CAS
No
Molecular Formula
C33H35FN2O5
Molecular Weight
558.600000
Exact Mass
558.253000
SMILES
CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
InChI
InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1
InChIKey
XUKUURHRXDUEBC-KAYWLYCHSA-N

Physical Properties

Melting Point
159.1 - 190.6 °C
Physical Description
Solid
State
Solid
Storage Conditions
Store at controlled room temperature 20-25 °C.

Computed Properties

Structural Parameters

Heavy atom count
41
Aromatic heavy atom count
23
Fraction Csp3
0.27
Rotatable bonds
12
H-bond acceptors
5
H-bond donors
4
Molar refractivity
157.25
TPSA
111.79

LogP / Solubility

WLOGP
6.31
MLOGP
5.6
XLogP3
5
Consensus LogP
5.64
Log S (ESOL)
-6.9
Class (ESOL)
Insoluble
Log S (Ali)
-8.7
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-9.97
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.65

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5.5

Safety & Transport

Pictogram(s)
Irritant Health Hazard
Signal
Warning
GHS Hazard Statements
H315 (66.7%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (66.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H335 (66.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] H361 (33.3%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] H361f (33.3%): Suspected of damaging fertility [Warning Reproductive toxicity]
Precautionary Statement Codes
P203, P260, P261, P263, P264, P264+P265, P270, P271, P280, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Get In Touch

Contact Us